A major pharmaceutical multi-national urgently required the implementation of a compliance system. Indian subsidiary was under pressure from its German parent to act swiftly.
The Mumbai‐based subsidiary urgently needed to adopt a statutory compliance framework in preparation for a global audit by the European parent. The key deliverables tasked to the WIL Group were:
1. Review local Statutory Compliance framework vs. parent company’s policies.
2. Define Compliance Checklist to pre-empt violations.
3. Recommend process for efficient handling of compliance violation investigation and preventive mechanism.
4. Develop and recommend Risk Matrix.
The WIL Group set up a multi‐functional team comprising of a finance manager and a legal professional to review the local statutory compliance environment and benchmark it against the parent company’s compliance framework.
The team interviewed various stakeholders within the organization to understand complexities and challenges; reviewed existing company policies, identified applicable local laws and developed a preventive and investigative mechanism to manage compliance violations
The WIL Group team structured a comprehensive compliance framework forthe company within three months. The final report included the compliance structure, a process for handling and mitigating compliance violations and a Risk Matrix for the company.
The recommended compliance framework adopted by the company successfully cleared the global audit by the European parent and was implemented by the local subsidiary.